Literature DB >> 30925560

Blood Substitutes and Oxygen Therapeutics: A Review.

Jonathan S Jahr1, Nicole R Guinn2, David R Lowery3,4, Linda Shore-Lesserson5, Aryeh Shander6,7.   

Abstract

Despite the exhaustive search for an acceptable substitute to erythrocyte transfusion, neither chemical-based products such as perfluorocarbons nor hemoglobin-based oxygen carriers have succeeded in providing a reasonable alternative to allogeneic blood transfusion. However, there remain scenarios in which blood transfusion is not an option, due to patient's religious beliefs, inability to find adequately cross-matched erythrocytes, or in remote locations. In these situations, artificial oxygen carriers may provide a mortality benefit for patients with severe, life-threatening anemia. This article provides an up-to-date review of the history and development, clinical trials, new technology, and current standing of artificial oxygen carriers as an alternative to transfusion when blood is not an option.

Entities:  

Year:  2021        PMID: 30925560     DOI: 10.1213/ANE.0000000000003957

Source DB:  PubMed          Journal:  Anesth Analg        ISSN: 0003-2999            Impact factor:   5.108


  7 in total

1.  Albumin-derived perfluorocarbon-based artificial oxygen carriers can avoid hypoxic tissue damage in massive hemodilution.

Authors:  Anna Wrobeln; Johannes Jägers; Theresa Quinting; Timm Schreiber; Michael Kirsch; Joachim Fandrey; Katja B Ferenz
Journal:  Sci Rep       Date:  2020-07-20       Impact factor: 4.379

2.  A Novel Cross-Linked Hemoglobin-Based Oxygen Carrier, YQ23, Extended the Golden Hour for Uncontrolled Hemorrhagic Shock in Rats and Miniature Pigs.

Authors:  Lei Kuang; Yu Zhu; Yue Wu; Kunlun Tian; Xiaoyong Peng; Mingying Xue; Xinming Xiang; Billy Lau; Fei Chuen Tzang; Liangming Liu; Tao Li
Journal:  Front Pharmacol       Date:  2021-05-12       Impact factor: 5.810

Review 3.  Current perspectives of artificial oxygen carriers as red blood cell substitutes: a review of old to cutting-edge technologies using in vitro and in vivo assessments.

Authors:  Nijaya Mohanto; Young-Joon Park; Jun-Pil Jee
Journal:  J Pharm Investig       Date:  2022-08-02

4.  Blood substitutes: Basic science, translational studies and clinical trials.

Authors:  Jonathan S Jahr
Journal:  Front Med Technol       Date:  2022-08-18

5.  Evaluating the Effects of Subnormothermic Perfusion with AP39 in a Novel Blood-Free Model of Ex Vivo Kidney Preservation and Reperfusion.

Authors:  Smriti Juriasingani; Ashley Jackson; Max Yulin Zhang; Aushanth Ruthirakanthan; George J Dugbartey; Emrullah Sogutdelen; Max Levine; Moaath Mandurah; Matthew Whiteman; Patrick Luke; Alp Sener
Journal:  Int J Mol Sci       Date:  2021-07-02       Impact factor: 5.923

Review 6.  Perfluorocarbon-based oxygen carriers: from physics to physiology.

Authors:  Johannes Jägers; Anna Wrobeln; Katja B Ferenz
Journal:  Pflugers Arch       Date:  2020-11-03       Impact factor: 3.657

Review 7.  Therapeutic Potential of Hemoglobin Derived from the Marine Worm Arenicola marina (M101): A Literature Review of a Breakthrough Innovation.

Authors:  Fareeha Batool; Eric Delpy; Franck Zal; Elisabeth Leize-Zal; Olivier Huck
Journal:  Mar Drugs       Date:  2021-06-29       Impact factor: 5.118

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.